Research location
Goyang-si
Gyeonggi-do, South Korea
Advertisement
Research activity in Goyang-si
Gyeonggi-do, South KoreaCureCurrent currently publishes aggregate city-level research activity for this location: 184 trials and 188 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Goyang-si
184 linked trials · page 1 of 4Pharmacopuncture for Aromatase Inhibitor Induced Arthralgia (AIA)NCT07789717 · 2026-01-05 · 1 site observation
RECRUITING
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast CancerNCT07085767 · 2025-11-03 · 1 site observation
RECRUITING
Viscum Album for TNBC on Adjuvant PembrolizumabNCT06920810 · 2025-03-19 · 1 site observation
RECRUITING
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid TumorsNCT06687941 · 2025-03-11 · 1 site observation
RECRUITING
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung CancerNCT06712355 · 2025-02-03 · 1 site observation
RECRUITING
A Research Study Comparing How Well Different Doses of the Medicine NNC0519-0130 Can Reduce Kidney Damage in People Living With Chronic Kidney DiseaseNCT06717698 · 2024-12-02 · 1 site observation
RECRUITING
Prospective Study of Ultrahypofractionated Proton Beam Therapy for Localized Prostate CancerNCT07699705 · 2024-11-04 · 1 site observation
RECRUITING
A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean ParticipantsNCT06246123 · 2024-02-27 · 1 site observation
RECRUITING
GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsNCT06265025 · 2024-02-20 · 1 site observation
RECRUITING
Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLCNCT06162221 · 2024-01-18 · 1 site observation
RECRUITING
A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.NCT05967689 · 2023-07-31 · 1 site observation
RECRUITING
A Phase 1/2 Study to Evaluate the Safety, Tolerability and PK of JIN-A02 in Patients With EGFR Mutant Advanced NSCLCNCT05394831 · 2023-07-30 · 1 site observation
RECRUITING
Surgical Outcome of BCS Using ICG-F in Breast Cancer Patients After Preoperative ChemotherapyNCT06780735 · 2023-07-06 · 1 site observation
RECRUITING
A Post Marketing Surveillance on Piqray in KoreaNCT05293470 · 2022-06-29 · 1 site observation
RECRUITING
A Study of Sigvotatug Vedotin in Advanced Solid TumorsNCT04389632 · 2020-06-08 · 1 site observation
RECRUITING
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac ToxicityNCT03418961 · 2017-11-01 · 1 site observation
RECRUITING
Robotic Bronchoscopy for Small Lung Nodules Without a Bronchus SignNCT07862816 · 2027-01-01 · 1 site observation
NOT_YET_RECRUITING
Edoxaban Versus Apixaban in Cancer-Associated Venous ThromboembolismNCT07852637 · 2026-11-01 · 1 site observation
NOT_YET_RECRUITING
Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)NCT07680790 · 2026-09-30 · 1 site observation
NOT_YET_RECRUITING
A Study to Evaluate Efficacy and Safety of HCP1803-4 in Patients With Essential HypertensionNCT07660796 · 2026-07-06 · 1 site observation
NOT_YET_RECRUITING
Muco-active Agent Use and Clinical Outcomes After Lung Cancer Diagnosis in Chronic Obstructive Pulmonary DiseaseNCT07712016 · 2026-06-01 · 1 site observation
ACTIVE_NOT_RECRUITING
WEgovy Real World Assessment of Weight Loss in KoreaNCT07280221 · 2025-11-10 · 1 site observation
ENROLLING_BY_INVITATION
A Multicentre, Prospective, Single-arm, Non-interventional Regulatory Post-marketing Surveillance (rPMS) Study to Investigate the Safety and Effectiveness of Wegovy® (Semaglutide) in Patients With Obesity and Patients With Overweight in Routine Clinical Practice in KoreaNCT07018544 · 2024-11-19 · 1 site observation
ENROLLING_BY_INVITATION
A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 MutationNCT06560645 · 2024-11-04 · 1 site observation
TERMINATED
A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis.NCT06372145 · 2024-04-16 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate Efficacy and Safety of HCP1803 Compared to RLD2001-1 in Patients with Essential HypertensionNCT06438172 · 2024-03-25 · 1 site observation
COMPLETED
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple SclerosisNCT06141486 · 2023-12-27 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisNCT06141473 · 2023-12-13 · 1 site observation
ACTIVE_NOT_RECRUITING
Efficacy and Safety of Hyperbaric Oxygen Therapy for Radiation Dermatitis in Patients with Localized Breast CancerNCT06158347 · 2023-11-06 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Progressive Pulmonary FibrosisNCT06025578 · 2023-10-25 · 2 site observations
ACTIVE_NOT_RECRUITING
A Study of Gimistotug (BGB-A445) in Combination With Other Investigational Agents in Participants With Non-Small Cell Lung CancerNCT06029127 · 2023-10-23 · 1 site observation
COMPLETED
A Study of Vobramitamab Duocarmazine in Participants With Metastatic Castration Resistant Prostate Cancer and Other Solid TumorsNCT05551117 · 2023-06-13 · 1 site observation
TERMINATED
Study for Participants Continuing From Pfizer-sponsored Palbociclib (a Study Medicine) StudiesNCT05226871 · 2022-07-07 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate Efficacy and Safety of HCP1803 in Patients With Essential HypertensionNCT05362110 · 2022-05-16 · 1 site observation
COMPLETED
A 24-week Prospective, Open-label, Multicenter, Single-arm rPMS Study in Real-world Setting for Atectura®NCT05217810 · 2022-05-09 · 1 site observation
ACTIVE_NOT_RECRUITING
A 24-week rPMS Study in Real-world Setting for EnerzairNCT05274425 · 2022-05-09 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTENCT05171049 · 2022-05-05 · 1 site observation
TERMINATED
A Study of Tucatinib or Placebo With Trastuzumab and Pertuzumab for Metastatic HER2+ Breast CancerNCT05132582 · 2022-03-07 · 1 site observation
ACTIVE_NOT_RECRUITING
Local and Regional Radiotherapy for Nipple Sparing Mastectomy With ImplantNCT05213962 · 2021-11-15 · 1 site observation
ENROLLING_BY_INVITATION
Retrospective Study to Describe the Real-world Treatment Patterns and Associated Clinical Outcomes in Patients With Metastatic Castration-resistant Prostates CancerNCT04801186 · 2021-09-28 · 1 site observation
COMPLETED
ER+/HER2- Locally Advanced or Metastatic Breast Cancer (ENZENO Study)NCT04669587 · 2021-07-26 · 1 site observation
UNKNOWN
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C)NCT04956640 · 2021-07-19 · 1 site observation
ACTIVE_NOT_RECRUITING
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE)NCT04777396 · 2021-05-18 · 1 site observation
COMPLETED
A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)NCT04777409 · 2021-05-18 · 1 site observation
COMPLETED
Study of Talazoparib With Enzalutamide in Men With DDR Gene Mutated mCSPCNCT04821622 · 2021-05-12 · 1 site observation
ACTIVE_NOT_RECRUITING
Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadjuvant ChemotherapyNCT06212440 · 2021-05-04 · 2 site observations
COMPLETED
A Phase 2 Study to Explore the Dose of HCP1803 in Patients With Essential HypertensionNCT04959305 · 2021-04-22 · 1 site observation
COMPLETED
Study of IDE397 in Participants With Solid Tumors Harboring MTAP DeletionNCT04794699 · 2021-04-14 · 1 site observation
ACTIVE_NOT_RECRUITING
Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid TumorsNCT04659603 · 2021-03-29 · 1 site observation
TERMINATED
Study of Cabozantinib in Combination With Atezolizumab Versus Second NHT in Subjects With mCRPCNCT04446117 · 2020-10-19 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.